Color Genomics Starts Initiative of Cutting Down Prices of Breast Cancer Genetic Testing

April 21, 2015 6:59 PM

5 0

Color Genomics, a company that specializes in genetic testing, has announced today that it will now offer tests that detect breast and ovarian cancer at a much lower price than what the main examination costs in the present.

Elad Gil, Color’s CEO, believes in making the test more accessible to the majority of the population. The company wants to democratize access to this kind of genetic examination because women should know the risk they are under, and in the case of positive results, they should be able to discuss the...

Also read: BRIEF-Draegerwerk sees FY net sales growth at lower end of forecast range

Read more

To category page